LescolXL (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Lescol drug offered from Novartis Pharmaceuticals Corporation. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | fluvastatin sodium |
| SUBSTANCE NAME: | FLUVASTATIN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-10-06 |
| END MARKETING DATE: | 0000-00-00 |
Lescol XL HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lescol XL from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80(mg/1) |
| START MARKETING DATE: | 2000-10-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0354_99e5618b-b1a7-4b80-ade0-e891ca6b5ddf |
| PRODUCT NDC: | 0078-0354 |
| APPLICATION NUMBER: | NDA021192 |
Other FLUVASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:
